|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
355,150,000 |
Market
Cap: |
2.51(B) |
Last
Volume: |
17,273,575 |
Avg
Vol: |
17,225,814 |
52
Week Range: |
$5.72 - $10.61 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
2 |
4 |
7 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Paulson John |
Director |
|
2024-03-29 |
4 |
A |
$10.61 |
$62,493 |
D/D |
5,890 |
208,309 |
|
- |
|
Icahn Brett |
Director |
|
2024-03-29 |
4 |
A |
$10.61 |
$33,124 |
D/D |
3,122 |
108,500 |
|
- |
|
Wechsler Amy B |
Director |
|
2024-03-29 |
4 |
A |
$10.61 |
$6,865 |
D/D |
647 |
169,906 |
|
- |
|
Robertson Russel C |
Director |
|
2024-03-29 |
4 |
A |
$10.61 |
$31,246 |
D/D |
2,945 |
225,279 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2024-03-04 |
4 |
AS |
$9.80 |
$61,867 |
D/D |
(6,313) |
499,905 |
|
-28% |
|
Barresi John S |
SVP, Controller & CAO |
|
2024-03-01 |
4 |
D |
$9.89 |
$31,529 |
D/D |
(3,188) |
107,064 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2024-03-01 |
4 |
D |
$9.89 |
$239,763 |
D/D |
(24,243) |
506,218 |
|
- |
|
Appio Thomas |
Chief Executive Officer |
|
2024-03-01 |
4 |
D |
$9.89 |
$1,156,952 |
D/D |
(116,982) |
1,369,356 |
|
- |
|
Barresi John S |
SVP, Controller & CAO |
|
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
39,126 |
110,252 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
147,536 |
530,461 |
|
- |
|
Appio Thomas |
Chief Executive Officer |
|
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
519,328 |
1,486,338 |
|
- |
|
Paulson John |
Director |
|
2023-12-29 |
4 |
A |
$8.02 |
$62,500 |
D/D |
7,793 |
202,419 |
|
- |
|
Robertson Russel C |
Director |
|
2023-12-29 |
4 |
A |
$8.02 |
$31,246 |
D/D |
3,896 |
222,334 |
|
- |
|
Wechsler Amy B |
Director |
|
2023-12-29 |
4 |
A |
$8.02 |
$6,873 |
D/D |
857 |
169,259 |
|
- |
|
Icahn Brett |
Director |
|
2023-12-29 |
4 |
A |
$8.02 |
$33,123 |
D/D |
4,130 |
105,378 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-12-05 |
4 |
AS |
$7.38 |
$1,624 |
D/D |
(220) |
382,925 |
|
23% |
|
Carson Seana |
EVP, General Counsel |
|
2023-12-01 |
4 |
D |
$7.36 |
$12,446 |
D/D |
(1,691) |
383,145 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-11-06 |
4 |
AS |
$7.61 |
$327 |
D/D |
(43) |
384,836 |
|
26% |
|
Carson Seana |
EVP, General Counsel |
|
2023-11-03 |
4 |
D |
$7.57 |
$2,528 |
D/D |
(334) |
384,879 |
|
- |
|
Icahn Brett |
Director |
|
2023-09-29 |
4 |
A |
$8.22 |
$33,118 |
D/D |
4,029 |
101,248 |
|
- |
|
Robertson Russel C |
Director |
|
2023-09-29 |
4 |
A |
$8.22 |
$31,244 |
D/D |
3,801 |
218,438 |
|
- |
|
Wechsler Amy B |
Director |
|
2023-09-29 |
4 |
A |
$8.22 |
$6,872 |
D/D |
836 |
168,402 |
|
- |
|
Paulson John |
Director |
|
2023-09-29 |
4 |
A |
$8.22 |
$62,497 |
D/D |
7,603 |
194,626 |
|
- |
|
Carson Seana |
EVP, General Counsel |
|
2023-09-06 |
4 |
AS |
$8.28 |
$55,352 |
D/D |
(6,685) |
385,213 |
|
0% |
|
Vadaketh Tom George |
EVP, Chief Financial Officer |
|
2023-09-05 |
4 |
D |
$8.35 |
$366,966 |
D/D |
(43,948) |
564,933 |
|
- |
|
1049 Records found
|
|
Page 1 of 42 |
|
|